Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 125


Immunohistochemical screening for the diagnosis of succinate dehydrogenase-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma.

Trpkov K, Siadat F.

Ann Transl Med. 2019 Dec;7(Suppl 8):S324. doi: 10.21037/atm.2019.09.143. No abstract available.


ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification.

Siadat F, Trpkov K.

Cancers (Basel). 2020 Jan 9;12(1). pii: E168. doi: 10.3390/cancers12010168. Review.


Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.

Michalova K, Tretiakova M, Pivovarcikova K, Alaghehbandan R, Perez Montiel D, Ulamec M, Osunkoya A, Trpkov K, Yuan G, Grossmann P, Sperga M, Ferak I, Rogala J, Mareckova J, Pitra T, Kolar J, Michal M, Hes O.

Ann Diagn Pathol. 2020 Feb;44:151448. doi: 10.1016/j.anndiagpath.2019.151448. Epub 2019 Dec 14.


Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.

Gandhi JS, Smith SC, Paner GP, McKenney JK, Sekhri R, Osunkoya AO, Baras AS, DeMarzo AM, Cheville JC, Rafael JE, Trpkov K, Colecchia M, Ro JY, Montironi R, Menon S, Hes O, Williamson SR, Hirsch MS, Netto GJ, Fine SW, Sirohi D, Kaushal S, Sangoi A, Robinson BD, Kweldam CF, Humphrey PA, Hansel DE, Schultz L, Magi-Galluzzi C, Przybycin CG, Shah RB, Mehra R, Kunju LP, Aron M, Kryvenko ON, Kench JG, Kuroda N, Tavora F, van der Kwast T, Grignon DJ, Epstein JI, Reuter VE, Amin MB.

Am J Surg Pathol. 2019 Dec 23. doi: 10.1097/PAS.0000000000001417. [Epub ahead of print]


"Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.

Shah RB, Stohr BA, Tu ZJ, Gao Y, Przybycin CG, Nguyen J, Cox RM, Rashid-Kolvear F, Weindel MD, Farkas DH, Trpkov K, McKenney JK.

Am J Surg Pathol. 2019 Dec 31. doi: 10.1097/PAS.0000000000001422. [Epub ahead of print]


Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases.

Pivovarčíková K, Martínek P, Trpkov K, Alaghehbandan R, Magi-Galluzzi C, Mundo EC, Berney D, Suster S, Gill A, Rychlý B, Michalová K, Pitra T, Hora M, Michal M, Hes O.

Cesk Patol. 2019 Fall;55(4):244-249.


High-grade Adenocarcinoma of the Prostate Mimicking Urothelial Carcinoma is Negative for TERT Mutations.

Alaghehbandan R, Vanecek T, Trpkov K, Comperat E, Kristiansen G, Svajdler M, Cempirkova D, Pavlovsky M, Pivovarcikova K, Stehlikova A, Hora M, Michal M, Hes O.

Appl Immunohistochem Mol Morphol. 2019 Aug;27(7):523-528. doi: 10.1097/PAI.0000000000000588.


Primary adenocarcinoma of bulbomembranous urethra: An exceedingly rare carcinoma in a male patient.

Stukalin I, Gao Y, Spaner S, Trpkov K, Gotto G.

Urol Case Rep. 2019 Jun 7;26:100941. doi: 10.1016/j.eucr.2019.100941. eCollection 2019 Sep.


ERG expression in prostate cancer biopsies with and without high-grade prostatic intraepithelial neoplasia: a study in Jordanian Arab patients.

Aldaoud N, Graboski-Bauer A, Abdo N, Al Bashir S, Oweis AO, Ebwaini H, Hasen Y, Alazab R, Trpkov K.

Res Rep Urol. 2019 May 22;11:149-155. doi: 10.2147/RRU.S207843. eCollection 2019.


Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting.

Kench JG, Judge M, Delahunt B, Humphrey PA, Kristiansen G, Oxley J, Rasiah K, Takahashi H, Trpkov K, Varma M, Wheeler TM, Zhou M, Srigley JR, Egevad L.

Virchows Arch. 2019 Sep;475(3):263-277. doi: 10.1007/s00428-019-02574-0. Epub 2019 May 16. Review.


High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex.

Trpkov K, Bonert M, Gao Y, Kapoor A, He H, Yilmaz A, Gill AJ, Williamson SR, Comperat E, Tretiakova M, Magi-Galluzzi C, Brimo F, Hes O.

Histopathology. 2019 Sep;75(3):440-442. doi: 10.1111/his.13876. Epub 2019 Jul 2. No abstract available.


Changes in risk-group stratification of patients undergoing radical prostatectomy at the Southern Alberta Institute of Urology over time.

Shiff B, Patel P, Trpkov K, Gotto GT.

Res Rep Urol. 2019 Mar 20;11:69-75. doi: 10.2147/RRU.S188966. eCollection 2019.


Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?

Trpkov K, Williamson SR, Gao Y, Martinek P, Cheng L, Sangoi AR, Yilmaz A, Wang C, San Miguel Fraile P, Perez Montiel DM, Bulimbasić S, Rogala J, Hes O.

Histopathology. 2019 Aug;75(2):174-184. doi: 10.1111/his.13865. Epub 2019 Mar 21.


The effect of time from biopsy to radical prostatectomy on adverse pathologic outcomes.

Patel P, Sun R, Shiff B, Trpkov K, Gotto GT.

Res Rep Urol. 2019 Mar 6;11:53-60. doi: 10.2147/RRU.S187950. eCollection 2019.


Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 cases.

Pivovarcikova K, Martinek P, Grossmann P, Trpkov K, Alaghehbandan R, Magi-Galluzzi C, Pane Foix M, Condom Mundo E, Berney D, Gill A, Rychly B, Michalova K, Rogala J, Pitra T, Micsik T, Polivka J, Hora M, Tanas Isikci O, Skalova S, Mareckova J, Michal M, Hes O.

Ann Diagn Pathol. 2019 Apr;39:63-68. doi: 10.1016/j.anndiagpath.2019.02.008. Epub 2019 Feb 10.


PTEN Loss in a Prostate Cancer Cohort From Jordan.

Al Bashir S, Alzoubi A, Alfaqih MA, Kheirallah K, Smairat A, Haddad H, Al-Dwairy A, Fawwaz BAB, Alzoubi M, Trpkov K.

Appl Immunohistochem Mol Morphol. 2019 Jan 4. doi: 10.1097/PAI.0000000000000732. [Epub ahead of print]


New and emerging renal entities: a perspective post-WHO 2016 classification.

Trpkov K, Hes O.

Histopathology. 2019 Jan;74(1):31-59. doi: 10.1111/his.13727. Review.


Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Egevad L, Judge M, Delahunt B, Humphrey PA, Kristiansen G, Oxley J, Rasiah K, Takahashi H, Trpkov K, Varma M, Wheeler TM, Zhou M, Srigley JR, Kench JG.

Pathology. 2019 Jan;51(1):11-20. doi: 10.1016/j.pathol.2018.10.003. Epub 2018 Nov 23.


Gleason Grading: Clear and Straightforward Rules Facilitate Judgment.

Trpkov K, Yilmaz A, Sangkhamanon S, Medlicott S, Donnelly B, Gotto G, Shea-Budgell M.

Am J Surg Pathol. 2019 Feb;43(2):291-292. doi: 10.1097/PAS.0000000000001176. No abstract available.


VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.

Wang L, Zhang Y, Chen YB, Skala SL, Al-Ahmadie HA, Wang X, Cao X, Veeneman BA, Chen J, Cieślik M, Qiao Y, Su F, Vats P, Siddiqui J, Xiao H, Sadimin ET, Epstein JI, Zhou M, Sangoi AR, Trpkov K, Osunkoya AO, Giannico GA, McKenney JK, Argani P, Tickoo SK, Reuter VE, Chinnaiyan AM, Dhanasekaran SM, Mehra R.

Am J Surg Pathol. 2018 Dec;42(12):1571-1584. doi: 10.1097/PAS.0000000000001150.


Supplemental Content

Loading ...
Support Center